← Back to Search

Behavioural Intervention

Resistance Exercise for Stroke Recovery (POWER-F Trial)

N/A
Recruiting
Research Sponsored by McMaster University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Able to walk >10 meters with or without the use of an assistive device
≥18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, over 13 months
Awards & highlights

POWER-F Trial Summary

This trial examines if a resistance exercise program can help improve muscle mass, strength & power after a stroke for better mobility & independence.

Who is the study for?
This trial is for adults over 18 who had a stroke at least 6 months ago, can walk more than 10 meters with or without help, live at home, and have mild to moderate stroke effects. People with heart issues like unstable chest pain or uncontrolled high blood pressure, severe thinking problems preventing safe exercise, or those in active stroke rehab cannot join.Check my eligibility
What is being tested?
The study tests if power-focused resistance training (exercises that improve muscle strength and power) is doable for people who've had a stroke. It looks at how this type of workout affects muscle mass, strength, overall fitness levels, heart health and walking independence after a stroke.See study design
What are the potential side effects?
While the trial's description doesn't list specific side effects of the exercises being tested, general risks may include muscle soreness or strain from physical activity. The eligibility criteria suggest avoiding participants with conditions where exercise could be unsafe.

POWER-F Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can walk more than 10 meters, with or without help like a cane.
Select...
I am 18 years old or older.
Select...
It has been over 6 months since my stroke.
Select...
My stroke has left me with slight to moderate disability.

POWER-F Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, over 13 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, over 13 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility: Attendance and attrition
Feasibility: Exercise tolerance
Feasibility: Participant recruitment
+3 more
Secondary outcome measures
30-second chair stand test
Global physical activity questionnaire
Isokinetic power
+5 more

POWER-F Trial Design

1Treatment groups
Experimental Treatment
Group I: Power TrainingExperimental Treatment1 Intervention
The program is intentionally designed with 3 progressive phases: Phase 1 Familiarization (Week 1) will allow participants to begin with a low-intensity version of the training program (body weight resisted or light weights at RPE 2-3 for 8 repetitions) to acclimate participants to the movements. Phase 2 Strength (Weeks 2-5) will progress in loads to achieve volitional fatigue between 5-8 repetitions (RPE 7-9). Phase 3 Power (Weeks 6-10) will use intensities between RPE 4-6 (15-20 repetitions) and execute each exercise at the highest possible velocity to focus on muscle power. The exercises, selected to emphasize functional movements relevant to daily activities.

Find a Location

Who is running the clinical trial?

McMaster UniversityLead Sponsor
884 Previous Clinical Trials
2,598,301 Total Patients Enrolled
21 Trials studying Stroke
41,722 Patients Enrolled for Stroke

Media Library

Power-focused resistance training (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05816811 — N/A
Stroke Research Study Groups: Power Training
Stroke Clinical Trial 2023: Power-focused resistance training Highlights & Side Effects. Trial Name: NCT05816811 — N/A
Power-focused resistance training (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05816811 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment in this trial open and ongoing?

"According to clinicaltrials.gov, this research is currently enlisting participants since its first posting on August 1st 2023 and most recent update on July 24th 2023."

Answered by AI

What is the cap on enrolment for this research project?

"Indeed, the data posted on clinicaltrials.gov shows that this research endeavour is actively recruiting participants. It was first published in August 1st 2023 and recently updated July 24th 2023 with a need for 15 subjects from one location."

Answered by AI

What results is this medical research endeavor striving to acquire?

"This 13-month long study aspires to assess the safety of this medication by evaluating serious and non-serious adverse events. Additionally, it will measure lower extremity strength and endurance with a 30 Second Chair Stand Test (30sCST), stroke-specific health related quality of life using Stroke Impact Scale 3.0 (SIS-3.0) comprised of 59 items measuring 8 domains, and functional mobility via Timed Up & Go test (TUG)."

Answered by AI
~1 spots leftby Jun 2024